logo
OpenAI employees share their 3 favorite tips for using ChatGPT

OpenAI employees share their 3 favorite tips for using ChatGPT

If you ever happen to see Nick Turley, the head of ChatGPT at OpenAI, muttering to himself on a weekday morning, it might be because he's talking to a chatbot.
Turley said that ChatGPT's voice feature is his favorite tip for using the technology on a recent episode of the OpenAI podcast.
"On my way to work, I'll use it to process my own thoughts. With some luck, and I think this works most days, I'll have the restructured list of to-dos by the time I actually get there," he said, adding that the voice feature isn't yet mainstream because there are a bunch of small "kinks" still. He said he finds it valuable to force himself to articulate his thoughts aloud, and wants to see the feature improve next year.
Mark Chen, OpenAI's chief research officer, said on the podcast that he's a fan of the deep research feature, especially before an introduction.
"When I go meet someone new, when I'm going to talk to someone about AI, I just preflight topics," Chen said. "I think the model can do a really good job of contextualizing who I am, who I'm about to meet, and what things we might find interesting."
And podcast host Andrew Mayne, who was formerly OpenAI's science communicator and worked on ChatGPT, said he uses the technology when he's out at a restaurant.
"I take a photograph of a menu and I'm like, 'Help me plan a meal or whatever, I'm trying to stick to a diet," Mayne said.
Turley, however, cautioned against using the same trick for the wine list. "It keeps embarrassing me with hallucinated wine recommendations, and I go order it and they're like, 'Never heard of this one,'" he said.
Corporate executives across companies are using AI in their daily lives, and OpenAI CEO Sam Altman is no different. Altman said on the "ReThinking" podcast in January that he uses it in "the boring ways," for things like processing emails and summarizing documents.
When Altman spoke on the OpenAI podcast in June, he said that he uses ChatGPT "constantly" as a father. At the time, he said he was mainly using it to research developmental stages.
"Clearly, people have been able to take care of babies without ChatGPT for a long time," Altman said. "I don't know how I would have done that."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Versailles Hospital Center adopts digital pathology platform
Versailles Hospital Center adopts digital pathology platform

Yahoo

time42 minutes ago

  • Yahoo

Versailles Hospital Center adopts digital pathology platform

The Versailles Hospital Center has begun a digital pathology transformation by selecting Tribun Health's CaloPix imaging platform. This move is a significant step in modernising the French public healthcare system's diagnostic services and integrating artificial intelligence (AI) into pathology. The implementation of CaloPix within the pathology department is set to streamline primary diagnostics and interdisciplinary collaboration. Tribun Health CEO Jean-François POMEROL said: 'This choice reflects a shared commitment to innovating for more effective, collaborative, and patient-centered healthcare.' Tribun Health's platform has a user-friendly interface and flexibility, catering to the dynamic requirements of hospital infrastructures. It is designed to be open and interoperable, allowing it to integrate with the hospital's digital strategy. This initiative is in line with the Versailles Hospital Center and GHT 78 Sud's digital objectives, which are coordinated with GHT Nord. It contributes to a national effort to upgrade and digitise healthcare facilities. Versailles Hospital Center is GHT 78 Sud's supporting institution. Versailles Hospital Center Pathology Department head Dr Claire GLASER said: 'The selection of CaloPix is fully aligned with our digital transformation strategy. We were impressed by the solution's user-friendliness, performance, and the quality of support offered by Tribun Health's teams. 'This project, developed in collaboration with the GHT Yvelines Nord, marks a key step for the future of our specialty in the region, particularly regarding AI and collaborative work. It also enhances our integration into APHP's expert networks equipped with the same software.' Tribun Health uses data-driven technology and AI to improve precision and minimise turnaround times to assist laboratories and hospitals in transitioning from glass slide pathology to complete digital solutions. "Versailles Hospital Center adopts digital pathology platform" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

Modella AI and AstraZeneca link for cancer clinical development
Modella AI and AstraZeneca link for cancer clinical development

Yahoo

time42 minutes ago

  • Yahoo

Modella AI and AstraZeneca link for cancer clinical development

Modella AI has signed a multi-year agreement with AstraZeneca to expedite AI-driven oncology clinical development. The partnership will give AstraZeneca access to Modella AI's multi-modal foundation models. The agreement will enable the use of Modella AI's latest models, with rich feature extraction from different types of data, to speed up clinical development across AstraZeneca's worldwide oncology portfolio. AstraZeneca oncology research and development (R&D) chief AI and data scientist Jorge Reis-Filho stated: 'At AstraZeneca, AI is integrated across every aspect of clinical development. 'Through the use of foundation models, combined with our unique datasets and AI expertise, we are confident in our strategy to accelerate development and increase the probabilities of success in our oncology clinical trials.' AstraZeneca will use Modella AI's platform for cancer research R&D capabilities to improve biomarker discovery and clinical development while enhancing patient outcomes. By integrating these advanced foundation models into its R&D pipeline, AstraZeneca seeks to enable data-driven discovery methods with increased speed. Modella AI CEO Jill Stefanelli stated: 'Foundation models are transforming precision medicine. They are the backbone of AI-powered biomedical discovery and mark the first step toward fully autonomous AI agents. 'Our state-of-the-art multimodal foundation models provide powerful features from different data types for downstream tasks. When integrated with AstraZeneca's research engine, they will have the potential to accelerate data-driven development and enable the development of new AI agents that can automate complex R&D workflows.' In June 2025, the US Food and Drug Administration (FDA) approved AstraZeneca and Daiichi Sankyo's Datroway (datopotamab deruxtecan) for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) that exhibits mutations in the epidermal growth factor receptor. "Modella AI and AstraZeneca link for cancer clinical development" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Can Spotify's Reliance on AI-Powered Offerings Drive Growth?
Can Spotify's Reliance on AI-Powered Offerings Drive Growth?

Yahoo

time42 minutes ago

  • Yahoo

Can Spotify's Reliance on AI-Powered Offerings Drive Growth?

Spotify Technology S.A. SPOT has consistently focused on integrating AI to personalize its offerings. This approach has helped the company's steady growth in user engagement reinforce its leadership in the audio streaming market. The AI DJ feature, launched in 2023, continues to resonate with users, with reports indicating high engagement. In the first quarter of 2023, SPOT had 515 million monthly active users (MAU), which increased 16.9% in the fourth quarter of 2023. The company then reported 615 million MAU, marking an increase of 2.1% from the previous quarter. This figure grew nearly 10% by the end of the fourth quarter of 2024. In the most recent March quarter, Spotify reported 678 million MAU, adding 3 million from the previous quarter and rising 10.2% from the same quarter last year. SPOT's AI DJ partially contributed to MAU growth, as other AI-powered features enhanced the user experience. Spotify Wrapped, an AI-driven personalized summary of listening habits, remains a strong tool for retention and engagement. In the recent earnings call, management explained that the slowdown in the first quarter was due to the strong performance of Spotify Wrapped in the previous quarter. This feature is likely to boost user engagement again in the second half of the year as well. Spotify's AI Playlist feature is gaining traction, which allows premium users to create playlists from prompts, and it has expanded to more than 40 new markets in April 2025. This feature improves the value proposition of a paid subscription, contributing toward average year-over-year revenue per user growth of 4% in the first quarter of 2025. The company has also utilized AI in optimizing its ad targeting for a significant proportion of its ad-supported user base, enhancing its user engagement. In doing so, SPOT registered 8% year-over-year growth in ad-supported revenues and witnessed an 885-basis-point increase in its ad-supported gross margin. The company has enhanced its focus on AI-based offerings up a notch by accepting audiobooks from ElevenLabs, an AI software company that offers high-quality voice narration technology. Authors can now use the ElevenLabs platform to narrate their audiobooks in 29 languages and distribute the content to Spotify, expanding their reach. That said, the global audiobooks market is anticipated to grow, seeing a CAGR of 26.2% from 2025 to 2030. Partnering with ElevenLabs is a strategic move for Spotify, allowing it to extend its global reach, strengthen its competitive moat and monetize its enormous global audience. The SPOT stock has skyrocketed 128.8% in the past year, significantly outperforming Amazon AMZN and Apple AAPL, and the industry as a whole. The industry has rallied 32%. Amazon has gained 11.7%, while Apple has declined 5.2%. Image Source: Zacks Investment Research From a valuation standpoint, SPOT trades at a forward price-to-earnings ratio of 64.34X, higher than Amazon's 33.26X, Apple's 28.33X and the industry's 39.73X. Image Source: Zacks Investment Research Spotify has a Value Score of F, while Amazon and Apple have a Value Score of D, respectively. The Zacks Consensus Estimate for Spotify's earnings for 2025 is pegged at $9.22 per share, implying 55% year-over-year growth. Image Source: Zacks Investment Research SPOT currently has a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Inc. (AMZN) : Free Stock Analysis Report Apple Inc. (AAPL) : Free Stock Analysis Report Spotify Technology (SPOT) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store